Nisa Investment Advisors’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-3,686
| Closed | -$634 | – | 2385 |
|
|
2021
Q3 | $634 | Sell |
3,686
-2,582
| -41% | -$338K | ﹤0.01% | 1051 |
|
|
2021
Q2 | $787 | Hold |
6,268
| – | – | ﹤0.01% | 1014 |
|
|
2021
Q1 | $850 | Buy |
6,268
+300
| +5% | +$38.8K | 0.01% | 1024 |
|
|
2020
Q4 | $764K | Buy |
5,968
+2,242
| +60% | +$263K | ﹤0.01% | 1033 |
|
|
2020
Q3 | $419K | Buy |
3,726
+150
| +4% | +$14.9K | ﹤0.01% | 1097 |
|
|
2020
Q2 | $341K | Buy |
3,576
+2,291
| +178% | +$221K | ﹤0.01% | 1149 |
|
|
2020
Q1 | $115K | Sell |
1,285
-320
| -20% | -$24.9K | ﹤0.01% | 1333 |
|
|
2019
Q4 | $85K | Sell |
1,605
-2,695
| -63% | -$123K | ﹤0.01% | 1462 |
|
|
2019
Q3 | $170K | Buy |
4,300
+4,090
| +1,948% | +$177K | ﹤0.01% | 1361 |
|
|
2019
Q2 | $9K | Hold |
210
| – | – | ﹤0.01% | 1795 |
|
|
2019
Q1 | $10K | Hold |
210
| – | – | ﹤0.01% | 1770 |
|
|
2018
Q4 | $9K | Hold |
210
| – | – | ﹤0.01% | 1687 |
|
|
2018
Q3 | $12K | Hold |
210
| – | – | ﹤0.01% | 1682 |
|
|
2018
Q2 | $10K | Hold |
210
| – | – | ﹤0.01% | 1745 |
|
|
2018
Q1 | $8K | Sell |
210
-150
| -42% | -$6.38K | ﹤0.01% | 1723 |
|
|
2017
Q4 | $15K | Hold |
360
| – | – | ﹤0.01% | 1630 |
|
|
2017
Q3 | $13K | Hold |
360
| – | – | ﹤0.01% | 1677 |
|
|
2017
Q2 | $11K | Buy |
360
+150
| +71% | +$4.35K | ﹤0.01% | 1702 |
|
|
2017
Q1 | $6K | Sell |
210
-190
| -48% | -$5.01K | ﹤0.01% | 1792 |
|
|
2016
Q4 | $10K | Buy |
+400
| New | +$12.7K | ﹤0.01% | 1807 |
|
Nisa Investment Advisors's XLRN Position: Q4 2021 in Review
Nisa Investment Advisors sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 3,686 shares — an estimated $634 sold.
Nisa Investment Advisors first reported a position in XLRN in Q4 2016 and held it in 20 quarters. The position peaked at $764K in Q4 2020. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.
- Nisa Investment Advisors reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
- Nisa Investment Advisors sold 3,686 Acceleron Pharma shares in Q4 2021, an estimated $634.
- Nisa Investment Advisors first reported a position in Acceleron Pharma in Q4 2016 and held it in 20 quarters.
- Nisa Investment Advisors's Acceleron Pharma position peaked at $764K in Q4 2020.
- 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.
Based on Nisa Investment Advisors's 13F filing for Q4 2021, filed 3 Feb 2022.